LIVER-DISEASE, AMINOGLYCOSIDE ANTIBIOTICS AND RENAL DYSFUNCTION

被引：15

作者：

LIETMAN, PS

机构：

来源：

HEPATOLOGY | 1988年 / 8卷 / 04期

关键词：

D O I：

10.1002/hep.1840080442

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：966 / 968

页数：3

共 17 条

[1]

CABRERA J, 1982, GASTROENTEROLOGY, V82, P97

[2] COMPARATIVE-STUDY OF AMINOGLYCOSIDE NEPHROTOXICITY IN NORMAL RATS AND RATS WITH EXPERIMENTAL CIRRHOSIS [J].

CAMPS, J ;

SOLA, X ;

RIMOLA, A ;

PARES, A ;

RIVES, A ;

SALMERON, JM ;

ARROYO, V ;

RODES, J .

HEPATOLOGY, 1988, 8 (04) :837-844

[3]

DESAI TK, IN PRESS AM J MED

[4] CEFOTAXIME IS MORE EFFECTIVE THAN IS AMPICILLIN-TOBRAMYCIN IN CIRRHOTICS WITH SEVERE INFECTIONS [J].

FELISART, J ;

RIMOLA, A ;

ARROYO, V ;

PEREZAYUSO, RM ;

QUINTERO, E ;

GINES, P ;

RODES, J .

HEPATOLOGY, 1985, 5 (03) :457-462

[5]

LUFT FC, 1981, RES COMMUN CHEM PATH, V34, P89

[6] RISK-FACTORS FOR NEPHROTOXICITY IN PATIENTS TREATED WITH AMINOGLYCOSIDES [J].

MOORE, RD ;

SMITH, CR ;

LIPSKY, JJ ;

MELLITS, ED ;

LIETMAN, PS .

ANNALS OF INTERNAL MEDICINE, 1984, 100 (03) :352-357

[7] INCREASED RISK OF RENAL DYSFUNCTION DUE TO INTERACTION OF LIVER-DISEASE AND AMINOGLYCOSIDES [J].

MOORE, RD ;

SMITH, CR ;

LIETMAN, PS .

AMERICAN JOURNAL OF MEDICINE, 1986, 80 (06) :1093-1097

[8] RISK-FACTORS FOR THE DEVELOPMENT OF AUDITORY TOXICITY IN PATIENTS RECEIVING AMINOGLYCOSIDES [J].

MOORE, RD ;

SMITH, CR ;

LIETMAN, PS .

JOURNAL OF INFECTIOUS DISEASES, 1984, 149 (01) :23-30

[9] A MODEL FOR PREDICTING NEPHROTOXICITY IN PATIENTS TREATED WITH AMINOGLYCOSIDES [J].

SAWYERS, CL ;

MOORE, RD ;

LERNER, SA ;

SMITH, CR .

JOURNAL OF INFECTIOUS DISEASES, 1986, 153 (06) :1062-1068

[10] STUDIES OF RISK-FACTORS FOR AMINOGLYCOSIDE NEPHROTOXICITY [J].

SMITH, CR ;

MOORE, RD ;

LIETMAN, PS .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1986, 8 (05) :308-313

← 1 2 →